ACT Enact Holdings, Inc. Insider Trading

Genworth Holdings (10% owner) sold 605.1K shares of ACT at $42.28 on 2026-06-30 ($25.6M); retains 111.60M shares.

Genworth Holdings sold 605,067 shares at $42.28, representing a -0.5% reduction in its 112.21M-share position. The current price of $45.39 is -1.3% from the 52-week high of $46.00, and the stock has risen +10.5% over the past 30 days and +9.8% over 90 days, suggesting the sale occurred during a period of positive momentum. At the same ticker ACT, Genworth's prior five sales show mixed timing outcomes: only 1 of 3 measurable 90-day outcomes was well-timed, with results ranging from +11.3% to -4.8%. The company's fundamentals show a P/E of 8.05 with revenue of $312,069,000.00 and net income of $204,735,000.00 in the latest quarter, reflecting a stable operational profile.

Genworth Holdings (10% owner) sold 602,440 ACT shares at $42.91 on 2026-05-29; stock down 8.3% from 52-week high.

Genworth Holdings, a major 10% shareholder of Enact Holdings, executed a modest sale of 602,440 shares (representing -0.5% of pre-transaction holdings) at $42.91, above the current price of $41.09. At the same-ticker level, Genworth has conducted 5 prior sells at ACT with mixed timing: 2 of 5 achieved negative 90-day returns after the sale (well-timed), while 3 of 5 achieved positive 90-day returns (poorly timed). The cross-ticker track record shows an average 90-day return of +3.6% after Genworth's prior sells, indicating that historically this insider's sales have preceded stock rallies rather than declines. ACT itself is trading 8.3% below its 52-week high and down 3.5% over 30 days, providing context for the sale price relative to recent weakness but not definitively signaling a timing advantage.

Large 10% owner Genworth Holdings sells $23.8M stake in Enact Holdings amid modest price recovery.

Genworth Holdings, a substantial institutional holder with roughly one-tenth of Enact's shares outstanding, executed a large portfolio sale representing less than one-half percent of its total position. This is routine portfolio management by a fund rather than a signal of executive concern—Genworth has no operational role at Enact and its trading decisions reflect capital reallocation, not insider knowledge of deteriorating business conditions. The timing is unremarkable: Enact's stock has recovered modestly from its lows and is trading only slightly below its recent peak, a normal window for institutional rebalancing rather than a panic exit. With Enact posting solid profitability and modest revenue growth, and trading at a reasonable valuation multiple, the sale appears to be passive index rebalancing or opportunistic trimming of a large position rather than a vote of no confidence in the company's fundamentals.

10% Owner Genworth sells 820.6K shares of Enact Holdings (ACT) for $33.6M at $40.92; stock now at $40.57

Genworth Holdings, a 10% owner, sold 820,567 shares for $33,579,571.00 on 2026-03-31, representing a -0.7% reduction in its 114.19M share stake. The sale occurred at $40.92, while the stock currently trades at $40.57, approximately -8.2% from its 52-week high of $44.19. Examining the insider's same-ticker history at ACT reveals a pattern worth noting: of 5 prior trades, only 3 have reached measurable 90-day outcomes, and 0 of those 3 were well-timed sales (stock rose after each prior sale rather than declined). The cross-ticker track record shows 20 prior sells with a 22.22% well-timed rate, but that broad-based performance does not apply to ACT specifically, where the insider has consistently sold into gains rather than ahead of declines. Enact's fundamentals show a $5.7B market cap with strong profitability ($204.7M net income on $311.5M quarterly revenue) and a modest 7.28 P/E ratio, suggesting the sale is not driven by fundamental deterioration. The transaction appears routine in scale relative to the position and does not signal material conviction shift.

10% owner Genworth Holdings sells 398.7K ACT shares at $42.19; stock up 6.7% in 30 days, modest position reduction of 0.3%

Genworth Holdings sold 398,731 shares of Enact Holdings at $42.19 on 2026-02-27, reducing its stake from 114.59M to 114.19M shares—a reduction of 0.3% of pre-transaction holdings. The sale occurred during a period of near-term price strength: ACT has gained 6.7% over the prior 30 days and 9.2% over 90 days, though it remains 4.0% below its 52-week high of $44.19. The company's fundamentals show robust profitability with $204.7M in net income on $311.5M quarterly revenue and a lean P/E of 7.62, indicating modest valuation. Genworth's prior sells at this ticker show a mixed timing record: among three measurable 90-day outcomes, none were well-timed (all generated positive returns, meaning the stock rose after the sales). The current sale's timing cannot yet be assessed, but the pattern suggests the insider's sell activity at ACT has not historically preceded price declines.

Genworth Holdings (10% owner) sold 635.0K ACT shares at $39.37 on 2026-01-30; stock now $40.45, up 2.1% in 30 days

Genworth Holdings, a major shareholder, sold 634,953 shares for $24,995,623.29 on 2026-01-30, reducing holdings from 115.22M to 114.59M shares. At the transaction price of $39.37, this sale has underperformed in the near term—the stock rose 2.1% over 30 days and now trades at $40.45, suggesting the seller missed modest near-term upside. Across Genworth's same-ticker history at ACT, prior sales have yielded mixed results: three measurable 90-day outcomes show no well-timed sells (0 of 3), with outcomes ranging from +4.6% to +10.9%. The cross-ticker track record (20 prior sells, 22.22% well-timed rate) provides limited predictive power for this specific ticker, where the timing pattern has been unfavorable. ACT trades near its 52-week high ($40.68) on solid fundamentals (P/E 8.85, quarterly net income $204.7M), offering no obvious technical or valuation signal that would justify the sale as defensive positioning.

Genworth Holdings (10% owner) sells 908,673 ACT shares for $35.9M at $39.47; stock near 52-week highs, mixed timing history

Genworth Holdings, a 10% stakeholder, sold 908,673 shares (908.7K shares) for $35,863,960.30 ($35.9M) at $39.47 on 2025-12-31, reducing its position by 0.8% to 115,223,783 shares (115.22M shares). The sale occurred near ACT's 52-week highs—the stock was -2.5% from the 52-week high of $40.62—which is typically when large holders elect to exit. Genworth's prior five trades at ACT show inconsistent timing: only 1 of 3 measurable 90-day outcomes was well-timed (a -2.5% return on the 2025-07-31 sale). The company's fundamentals remain solid (P/E 8.67, $311.5M quarterly revenue, $204.7M net income, +4.2% annual growth), and the stock's 30-day momentum is positive (+2.6%). This sale does not represent a forced liquidation or distressed exit; it is a modest reduction by a large holder at elevated valuation.

10% owner Genworth Holdings sells 878,006 ACT shares for $32.8M; stock up 9% in 30 days since trade

Genworth Holdings, a 10% owner of Enact Holdings, sold 878,006 shares (878.0K shares) at $37.36 on 2025-11-28 for $32,804,147.97 ($32.8M), reducing holdings to 116,132,456 shares (116.13M shares). The sale represents a 0.8% reduction in position size. ACT has appreciated 9.0% in the 30 days following the sale, trading near its 52-week high of $39.23 and currently at $38.93. Across Genworth's cross-ticker open-market sell history, its 90-day well-timed rate stands at 22.22%, indicating that sales have been poorly-timed on average; at ACT specifically, only 1 of 3 measurable prior sales resulted in post-sale declines. The company trades at a P/E of 8.52 with net income of $204,735,000.00 ($204.7M) on annual revenue of $311,455,000.00 ($311.5M) and reported revenue growth of 4.2% year-over-year. The sale occurred as the stock was already appreciating, with limited evidence that this transaction preceded deterioration in the position.

Genworth Holdings (10% owner) sells 940.8K ACT shares at $36.19 for $34.1M; stock down -8.5% from 52-week high.

Genworth Holdings, a substantial 10% shareholder, divested 940,819 shares (940.8K shares) of Enact Holdings at $36.19, reducing holdings from 117,951,281 to 117,010,462 shares in an open-market sale valued at $34,051,438.39. The sale occurred near the upper end of the stock's recent range—$35.90 current price is -8.5% from the 52-week high of $39.23—suggesting execution at a relatively favorable pricing window. At this transaction price, the insider sold above the current market level, though the stock has retreated -2.4% over the 30-day period following the trade. The underlying company reports strong fundamentals: $304.9M quarterly revenue with $204.7M net income, +4.2% annual growth, and an attractive P/E of 8.01; however, this disciplined exit by a major shareholder during a mild retreat warrants investor attention to whether the position remains strategically aligned with long-term holdings.

10% owner Genworth Holdings sells 922.2K shares of ACT at $38.35 (Sept 2025); holds 117.95M shares post-sale.

Genworth Holdings, a substantial 10% shareholder, sold 922,169 shares at $38.35 on 2025-09-30, reducing its holding by 0.8%. The current price of $37.86 sits 3.5% below the 52-week high, with the stock flat on a 90-day basis (+0.2%). At the same-ticker level, Genworth's prior five trades at ACT show a 0% well-timed sell rate at the 90-day mark—in three measurable outcomes, none preceded a decline, with the most recent 2025-06-30 sale followed by a +10.2% 90-day gain. The company itself trades at a tight P/E of 8.45 on $304.9M quarterly revenue and $204.7M net income. This sale fits a pattern of regular quarterly dispositions by this major stakeholder; the transaction's small size relative to the $5.6B market cap and the insider's lack of demonstrated sell-timing skill at this ticker limit its interpretive weight.